Sign in

CIK 0001796280 · Non-accelerated filer

Oric Pharmaceuticals, Inc.

Sign in to watch
Ticker
ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471787157
Phone
(650) 388-5600
Business address
240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Option exercise Director acquired 10,000 shares (option exercise)
  2. 4 Option exercise Director acquired 5,534 shares (option exercise)
  3. 4 Planned sale Chief Financial Officer sold 11,000 shares at $14.52 ($159,719)
  4. 4 Planned sale PRESIDENT AND CEO sold 37,461 shares at $12.32 ($461,520)
  5. 4 Option exercise Director acquired 32,800 shares (option exercise)
  6. 4 Planned sale PRESIDENT AND CEO sold 87,539 shares at an average $12.04 ($1,053,555)
  7. 4 Planned sale PRESIDENT AND CEO sold 125,000 shares at $10.80 ($1,349,938)
  8. 4 Planned sale Chief Financial Officer sold 20,000 shares at $10.05 ($200,972)
  9. 4 Planned sale Chief Financial Officer sold 33,500 shares at an average $10.49 ($351,384)
  10. 4 Open-market buy Director bought 28,000 shares at an average $9.39 ($262,899)
  11. 4 Planned sale Chief Financial Officer sold 300 shares at $10.00 ($3,000)
  12. 4 Planned sale Chief Financial Officer sold 3,300 shares at an average $10.01 ($33,017)
  13. 4 Planned sale Chief Financial Officer sold 2,900 shares at an average $10.01 ($29,021)
  14. 4 Option exercise Director acquired 48,166 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 9 · 166 filings